StockWatch
·

Sundaram-Clayton Ltd

BSE: 544066

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
631.87
+19.7%+36.5%
Expenditure
578.70
+14.6%+32.4%
Net Profit
39.48
+131.7%+95.5%
OPM %
15.32%
+3.35pp-0.99pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00176.92353.85530.77707.69Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Consolidated loss narrows to ₹50.8 Cr; standalone PAT jumps 96% as US drag persists

auto components · aluminium die-casting · consolidated loss

ResultsQ2 FY2704 Nov 20263 minAutomobile

Sundaram-Clayton Q1: ₹59 Cr consolidated loss despite 16% revenue growth, US arm drags

auto components · aluminium diecasting · consolidated loss

ResultsQ1 FY2728 Jul 20263 minAutomobile
Latest
Board Meeting4 Nov, 1:04 pm

Consolidated loss narrows to ₹50.8 Cr; standalone PAT jumps 96% as US drag persists

Sundaram-Clayton's consolidated net loss narrowed to ₹50.8 Cr in Q2 FY27 from ₹64.4 Cr a year ago and ₹59.3 Cr last quarter, as revenue grew 41% YoY (18% QoQ) to ₹697.7 Cr. On a standalone basis — which excludes the loss-making US operations — the print was far stronger: revenue grew 37% YoY to ₹629.4 Cr and PAT nearly doubled to ₹39.5 Cr from ₹20.2 Cr, taking EPS to ₹17.91 from ₹9.16. The divergence is the story: India operations are solidly profitable and accelerating, while the US subsidiary continues to post losses large enough to pull the consolidated book into the red. Consolidated NPM improved to -7.3% from -12.9% a year ago and -10.0% last quarter, confirming the loss is narrowing on an operating basis and not just at the net line. On the standalone book, management's own numbers show EBITDA of ₹98.9 Cr at a 15.7% margin, up from ₹79.1 Cr in absolute terms but down from a 17.1% margin a year ago — alloy, energy and logistics cost pressure diluted the margin even as volumes and PAT grew; the bottom line was helped by lower finance costs (₹16.6 Cr vs ₹19.9 Cr) even as the effective tax rate rose. Per the auditor's review note, the unreviewed US entities alone carried a net loss of ₹90.5 Cr on revenue of ₹83.1 Cr for the quarter, underscoring that the US business remains the primary drag on the consolidated result even as "production at the US facility continued to ramp up," per the company. No prior management guidance or concall commentary is on record for this quarter, and no sell-side consensus estimates for Q2 FY27 could be located, so vsGuidance and vsStreet are both unknown. There were no exceptional items in either the current or year-ago quarter (unlike Q4 FY26, which carried a ₹521.2 Cr asset-sale gain), so the YoY comparison is clean. Demand tailwinds cited by management include M&HCV volumes up 23% YoY in H1 (33% in Q2, aided by pre-buying ahead of an October price hike) and passenger-vehicle volumes up 24% YoY on GST 2.0-aided affordability; in the US, Class 8 retail sales rose 10% YoY in Q3 CY2026 with production up 53%, which management frames as an improving backdrop for the ramping US facility. Separately, the board approved raising up to ₹700 Cr via NCDs/other borrowings, a balance-sheet action concurrent with the results but not yet reflected in this quarter's numbers. Management says it remains focused on a "financial turnaround" at the US operations "through appropriate restructuring and improvements in production and operating metrics" — its own stated aim, not a projection being made here. The next quarters will show whether the US ramp-up sustains the pace of loss-narrowing seen this quarter (down ~14% QoQ, ~21% YoY), and whether standalone margins stabilize as input-cost pressure persists.

4 Nov 2026, 01:04 pm

Corporate Events

Board MeetingSUNCLAY
2026
4Nov

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingSUNCLAY
2026
28Jul

Board Meeting

To consider and approve the Standalone and Consolidated Audi…

BSE Filing ↗
DividendSUNCLAY
2026
3Apr

₹4.5 / share

BSE Filing ↗
Board MeetingSUNCLAY
2026
27Mar

Board Meeting

To consider and approve the declaration of an interim divide…

BSE Filing ↗
Board MeetingSUNCLAY
2025
6Nov

Board Meeting

considering and approving Unaudited (Limited Reviewed) finan…

BSE Filing ↗
Board MeetingSUNCLAY
2025
6Aug

Board Meeting

consider and approve Unaudited (Limited Reviewed) financial …

BSE Filing ↗
Board MeetingSUNCLAY
2025
6May

Board Meeting

Consider and approve the annual audited Standalone and Conso…

BSE Filing ↗
DividendSUNCLAY
2025
27Mar

₹4.75 / share

BSE Filing ↗
Board MeetingSUNCLAY
2025
31Jan

Board Meeting

considering and approving, inter-alia, Unaudited (Limited Re…

BSE Filing ↗
Board MeetingSUNCLAY
2024
12Nov

Board Meeting

consider and approve inter-alia, Unaudited (Limited Reviewed…

BSE Filing ↗
Board MeetingSUNCLAY
2024
3Jul

Board Meeting

transacting the proposal of raising of funds by way of issua…

BSE Filing ↗